Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the

R Rozemeijer1, W P van Bezouwen2, N D van Hemert2

  • 1Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands. r.rozemeijer@umcutrecht.nl.

Insights

The CREDO-Kyoto score moderately predicts post-discharge ischemic or bleeding events after stenting, outperforming PARIS and PRECISE-DAPT scores in this patient group. Further research is needed to enhance risk stratification robustness.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Risk Stratification

Background:

  • Percutaneous coronary intervention (PCI) necessitates effective risk stratification tools.
  • Existing scores like PRECISE-DAPT, PARIS, and CREDO-Kyoto aim to predict post-PCI ischemic or bleeding events.
  • Independent validation of these scores is crucial for clinical utility.

Purpose of the Study:

  • To evaluate and compare the predictive performance of the PRECISE-DAPT, PARIS, and CREDO-Kyoto risk scores.
  • To assess the accuracy of these scores in identifying post-discharge ischemic and bleeding events following PCI.
  • To determine the most reliable risk stratification tool in a contemporary patient cohort.

Main Methods:

  • A cohort of 1491 patients undergoing latest-generation drug-eluting stent implantation was analyzed.
  • PRECISE-DAPT, PARIS, and CREDO-Kyoto risk scores were calculated for each patient.
  • Performance was assessed using calibration, Harrell's c-statistics, net reclassification index, and decision curve analyses.

Main Results:

  • Post-discharge ischemic events occurred in 3.8% and bleeding events in 2.3% of patients within one year.
  • CREDO-Kyoto demonstrated moderate discrimination for ischemic events (c-statistic 0.68) and bleeding events (c-statistic 0.67).
  • PARIS and PRECISE-DAPT showed marginal discrimination for bleeding events, and PARIS for ischemic events.

Conclusions:

  • The PARIS and PRECISE-DAPT scores lacked resilience in predicting post-discharge bleeding events in this cohort.
  • The CREDO-Kyoto score offered moderate predictive capability for both ischemic and bleeding events.
  • Improved risk stratification strategies with enhanced robustness and rigorous testing are warranted.
Abstract

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
458
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.1K
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.7K
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
109
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
13.2K
Improving Translational Accuracy02:07

Improving Translational Accuracy

3.4K